Parikh, Neehar D.

Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis

Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and Treatment

Cited by 1,207

Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis

Rich, N. E., Oji, S., Mufti, A. R., Browning, J. D., Parikh, N. D., Odewole, M., Mayo, H., & Singal, A. G. (2018) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 486

Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis

Wolf, E., Rich, N. E., Marrero, J. A., Parikh, N. D., & Singal, A. G. (2021) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and Screening

Cited by 333

An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis

Atiq, O., Tiro, J., Yopp, A. C., Muffler, A., Marrero, J. A., Parikh, N. D., Murphy, C., McCallister, K., & Singal, A. G. (2017) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and Treatment

Cited by 266

Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis

Farvardin, S., Patel, J., Khambaty, M., Yerokun, O. A., Mok, H., Tiro, J. A., Yopp, A. C., Parikh, N. D., Marrero, J. A., & Singal, A. G. (2017) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and Screening

Cited by 185

Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms

Parikh, N. D., Singal, A. G., Hutton, D. W., & Tapper, E. B. (2020) · American Journal of Gastroenterology

Health Systems, Economic Evaluations, Quality of LifeHepatocellular Carcinoma Treatment and Prognosis

Cited by 163

Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium

Mehta, N., Frenette, C., Tabrizian, P., Hoteit, M., Guy, J., Parikh, N., Ghaziani, T. T., Dhanasekaran, R., Dodge, J. L., Natarajan, B., et al. (2021) · Gastroenterology

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 154

Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients

Sharma, P., Parikh, N. D., Yu, J., Barman, P., Derstine, B. A., Sonnenday, C. J., Wang, S. C., & Su, G. L. (2016) · Liver Transplantation

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 83

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma

Singal, A. G., Agopian, V. G., Dawson, L. A., El-Khoueiry, A., Finn, R. S., Halazun, K., Heimbach, J. K., Kelley, R. K., Kim, E., Kulik, L., et al. (2026) · Hepatology

Hepatocellular Carcinoma Treatment and PrognosisDelphi Technique in Research

Cited by 7